Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Cancer ; 43(10): 1581-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17446062

ABSTRACT

Central nervous system (CNS) atypical teratoid/rhabdoid tumours (AT/RT) are among the paediatric malignant tumours with the worst prognosis and fatal outcome. Insulin-like growth factor I receptor (IGF-IR) protects cancer cells from apoptosis induced by a variety of anticancer drugs and radiation. In the present study, IGF-IR was expressed in 8/8 primary AT/RT as detected by immunohistochemistry. Moreover, we found IGF-I and IGF-II mRNA in BT-16 CNS AT/RT cells and IGF-II mRNA in BT-12 CNS AT/RT cells, and autophosphorylated IGF-IR in both cell lines, indicating the potential presence of an autocrine/paracrine IGF-I/II/IGF-IR loop in CNS AT/RT. IGF-IR antisense oligonucleotide treatment of human CNS AT/RT cells resulted in significant down-regulation of IGF-IR mRNA and protein expression, induction of apoptosis, and chemosensitisation to doxorubicin and cisplatin. These studies provide evidence for the influence of IGF-IR on cellular responses to chemotherapy and raise the possibility that curability of selected CNS AT/RT may be improved by pharmaceutical strategies directed towards the IGF-IR.


Subject(s)
Apoptosis/drug effects , Central Nervous System Neoplasms/drug therapy , Oligoribonucleotides, Antisense/therapeutic use , Receptor, IGF Type 1/drug effects , Rhabdoid Tumor/drug therapy , Teratoma/drug therapy , Antineoplastic Agents/therapeutic use , Central Nervous System Neoplasms/pathology , Child , Child, Preschool , Cisplatin/therapeutic use , Down-Regulation , Doxorubicin/therapeutic use , Female , Humans , Infant , Insulin-Like Growth Factor I/metabolism , Male , Receptor, IGF Type 1/metabolism , Rhabdoid Tumor/pathology , Teratoma/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...